Multistate Point-Prevalence Survey of Health Care–Associated Infections
By S. Magill, J. Edwards, Wendy M. Bamberg, Z. Beldavs, G. Dumyati, M. Kainer, R. Lynfield, Meghan Maloney, Laura McAllister-Hollod, J. Nadle and 4 more. New England Journal of Medicine, 2014
3,441 citations recorded by the source corpus.
BACKGROUND Currently, no single U.S. surveillance system can provide estimates of the burden of all types of health care–associated infections across acute care patient populations. We conducted a prevalence survey in 10 geographically diverse states to determine the prevalence of health care–associated infections in acute care hospitals and generate updated estimates of the national burden of such infections. METHODS We defined health care–associated infections with the use of National Healthcare Safety Network criteria. One-day surveys of randomly selected inpatients were performed in participating hospitals. Hospital personnel collected demographic and limited clinical data. Trained data collectors reviewed medical records retrospectively to identify health care–associated infections active at the time of the survey. Survey data and 2010 Nationwide Inpatient Sample data, stratified according to patient age and length of hospital stay, were used to estimate the total numbers of health care–associated infections and of inpatients with such infections in U.S. acute care hospitals in 2011. RESULTS Surveys were conducted in 183 hospitals. Of 11,282 patients, 452 had 1 or more health care–associated infections (4.0%; 95% confidence interval, 3.7 to 4.4). Of 504 such infections, the most common types were pneumonia (21.8%), surgical-site infections (21.8%), and gastrointestinal infections (17.1%). Clostridium difficile was the most commonly reported pathogen (causing 12.1% of health care–associated infections). Device-associated infections (i.e., central-catheter–associated bloodstream infection, catheter-associated urinary tract infection, and ventilator-associated pneumonia), which have traditionally been the focus of programs to prevent health care–associated infections, accounted for 25.6% of such infections. We estimated that there were 648,000 patients with 721,800 health care–associated infections in U.S. acute care hospitals in 2011. CONCLUSIONS Results of this multistate prevalence survey of health care–associated infections indicate that public health surveillance and prevention activities should continue to address C. difficile infections. As device- and procedure-associated infections decrease, consideration should be given to expanding surveillance and prevention activities to include other health care–associated infections.
Subfields: Critical Care and Intensive Care Medicine, Infectious Diseases, Surgery
View Paper: https://www.semanticscholar.org/paper/e10c71ecc2944c86b1e4bcbe19c6138cac14245a
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Critical Care and Intensive Care Medicine
In Infectious Diseases
In Surgery
Citations in the corpus
- Invasive candidiasis (2018, methodology): “Combined use of serum (1,3)-β-D-glucan and procalcitonin for the early differential diagnosis between candidaemia and”
- The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update (2021, background): “Healthcare-associated pneumonia (HAP) and ventilatorassociated pneumonia (VAP) are a significant source of stress on the healthcare system, and they account for up to 22% of all healthcare-acquired infections [1, 6].”
- Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. (2016, background): “A recent multicenter point-prevalence survey identified Candida species as the most commonly isolated healthcare-associated bloodstream pathogen [4].”
- Colonization, Infection, and the Accessory Genome of Klebsiella pneumoniae (2018, background): “K. pneumoniae are the second leading cause of bloodstream infections (BSI) caused by Gram-negative bacteria, behind only E. coli (Podschun and Ullmann, 1998; Magill et al., 2014).”
- Proton pump inhibitors affect the gut microbiome (2015, background): “23 24 Virulent strains of C. dif fi cile can only colonise a susceptible gut, after which toxins are produced and spores are shed.”